CVS Health To Begin Nationwide In-Store Sales Of Biomerica's EZ Detect Colorectal Disease Screening Test
Portfolio Pulse from Happy Mohamed
Biomerica, Inc. (NASDAQ:BMRA) has announced that CVS Pharmacy will begin selling its EZ Detect colorectal disease screening test in over 7,000 stores nationwide. The product is expected to be on store shelves in September. Biomerica is also working with CVS Health to introduce an additional product to be sold in CVS pharmacies. The EZ Detect test is a simple at-home test that detects hidden blood in a person's stool, an early warning sign of colorectal diseases.
August 04, 2023 | 1:19 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Biomerica's EZ Detect colorectal disease screening test will be sold in CVS Pharmacy stores, potentially increasing the company's product exposure and sales.
The partnership with CVS Pharmacy, the largest pharmacy system in the USA, provides a significant opportunity for Biomerica to increase the exposure and sales of its EZ Detect test. This could potentially lead to increased revenues for the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
CVS Pharmacy will begin selling Biomerica's EZ Detect colorectal disease screening test in its stores, expanding its product offerings and potentially attracting more customers.
By selling Biomerica's EZ Detect test, CVS Pharmacy is expanding its product offerings, which could potentially attract more customers and increase sales. This could have a positive impact on the company's revenues.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100